Victoza Liraglutide Injection 6 mg

Q1: What is Victoza (Liraglutide 6mg/ml) used for?

Victoza is a once-daily injectable GLP-1 receptor agonist for type 2 diabetes. It improves blood sugar control, promotes significant weight loss, and has proven cardiovascular benefits — reducing the risk of major adverse cardiovascular events in type 2 diabetics with heart disease.

Q2: How does Liraglutide work to control blood sugar?

Liraglutide mimics the GLP-1 hormone, stimulating glucose-dependent insulin secretion (only when blood sugar is elevated), suppressing glucagon, slowing gastric emptying to reduce post-meal glucose spikes, and acting on brain appetite centres to reduce food intake.

Q3: How is Victoza injected?

Inject subcutaneously (under the skin) into the abdomen, thigh, or upper arm once daily using the pre-filled pen. Rotate injection sites to prevent lipohypertrophy. Victoza can be injected at any time of day, with or without meals.

Q4: What is the dose titration schedule?

Start with 0.6mg daily for 1 week (for GI adaptation). Increase to 1.2mg daily. If additional glycemic control is needed, increase to 1.8mg daily after at least 1 week at 1.2mg.

Q5: Does Victoza help with weight loss?

Yes. Victoza produces clinically meaningful weight loss — typically 2–4 kg — through appetite suppression and reduced caloric intake. This is a significant benefit compared to insulin or sulfonylureas which can cause weight gain.

Q6: Can Victoza cause low blood sugar?

Victoza alone has low hypoglycemia risk due to glucose-dependent insulin stimulation. Risk increases significantly when combined with insulin or sulfonylureas — your doctor may reduce those doses when adding Victoza.

Q7: What are the most common side effects?

Nausea (most common — affects ~20–30%, improves with time), vomiting, diarrhea, constipation, headache, and injection site reactions. These usually diminish after 4–8 weeks as the body adapts.

Q8: What serious side effects require immediate care?

Seek immediate care for: severe persistent abdominal pain (pancreatitis), gallbladder pain, significant unexplained weight loss, or a lump in the neck with difficulty swallowing (rare thyroid tumor risk — black box warning).

Q9: Is Victoza safe for patients with heart disease?

Yes — the LEADER trial demonstrated that Victoza (liraglutide 1.8mg) reduced cardiovascular death, non-fatal heart attack, and stroke by 13% compared to placebo in type 2 diabetics with established cardiovascular disease.

Q10: Can I use Victoza during pregnancy?

No. Victoza is not recommended during pregnancy. Women planning pregnancy should discuss transitioning to insulin for optimal safety during pregnancy.

Q11: How should I store Victoza pens?

Store unopened pens in the refrigerator at 2°C–8°C. Once a pen is in use, store at room temperature below 30°C and use within 30 days. Do not freeze. Protect from direct sunlight.

Q12: Do I need a prescription for Victoza?

Yes. Victoza requires a prescription. Your doctor will assess cardiovascular risk, kidney function, and thyroid history before prescribing, and will guide dose titration.